Rtw Investments, LP Celldex Therapeutics, Inc. Transaction History

Rtw Investments, LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$30.29 - $38.28 $11.5 Million - $14.5 Million	378,986 Added 12.29%	3,463,201 $118 Million
Q1 2022 May 16, 2022	SELL	$27.64 - $39.32 $23.1 Million - $32.9 Million	-837,364 Reduced 21.35%	3,084,215 $105 Million
Q4 2021 Feb 14, 2022	BUY	$35.68 - $56.27 $450,709 - $710,802	12,632 Added 0.32%	3,921,579 $152 Million
Q1 2021 May 14, 2021	BUY	$16.19 - $29.91 $7.87 Million - $14.5 Million	486,092 Added 14.2%	3,908,947 $80.5 Million
Q4 2020 Feb 16, 2021	BUY	$14.99 - $22.75 $4.54 Million - $6.89 Million	302,718 Added 9.7%	3,422,855 $60 Million
Q3 2020 Nov 16, 2020	BUY	$9.65 - $15.19 $4.92 Million - $7.75 Million	510,137 Added 19.55%	3,120,137 $46.3 Million
Q2 2020 Aug 14, 2020	BUY	$1.61 - $13.41 $4.2 Million - $35 Million	2,610,000 New	2,610,000 $33.9 Million

207

67.3M

1.69M

980K

Ticker CLDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,772,400
Market Cap $1.22B
Description
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...

Get notified when there are updates to the investment portfolio of Rtw Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Rtw Investments, LP with notifications on news.